Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Jun 15;25(12):2424-9.
doi: 10.1093/nar/25.12.2424.

Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site

R Galien  1 , T Garcia
Affiliations

Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site

R Galien et al. Nucleic Acids Res. .

Abstract

Interleukin-6 (IL-6) is a multifunctional cytokine thought to be a key factor in post-menopausal osteoporosis, given its ability to induce osteoclast maturation and its down regulation by estrogens. We have previously shown that the effects of TNFalphaand estradiol on the human IL-6 promoter were dependent on a region of the promoter containing a C/EBP site and a NF-kappaB site. To define the molecular mode of action of estrogens, we performed gel shift assays with this DNA fragment as a probe, and nuclear extracts from TNFalpha-induced HeLa, MCF7 and Saos2 cells. Several induced complexes specifically bound the probe. The use of various competitor DNA suggested that most of the complexes detected contained NF-kappaB factors, and that C/EBP site binding factors were important for the overall binding to the probe. Addition of in vitro translated human estrogen receptor (hER) impaired the binding of three complexes in HeLa cells and two complexes in MCF7 and Saos2 cells. Competition experiments suggested that the NF-kappaB site was necessary for the effect of hER. The use of antisera against NF-kappaB and C/EBP proteins showed that the target complexes of hER contained the c-rel proto-oncogene product and to a lesser extent, the RelA protein. Taken together, these data show that hER impairs TNFalphainduction of IL-6 by preventing c-rel and, to a lesser extent, RelA proteins binding to the NF-kappaB site of the IL-6 promoter.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Mol Endocrinol. 1995 Apr;9(4):401-12 - PubMed
    1. J Clin Invest. 1994 Mar;93(3):944-50 - PubMed
    1. J Biol Chem. 1996 Mar 29;271(13):7330-5 - PubMed
    1. J Biol Chem. 1996 Mar 8;271(10):5595-602 - PubMed
    1. Biochem Soc Trans. 1995 Nov;23(4):952-8 - PubMed

MeSH terms